Cambridge Investment Research Advisors, Inc. Natera, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,691 shares of NTRA stock, worth $233,358. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,691
Previous 1,679
0.71%
Holding current value
$233,358
Previous $266,000
10.15%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NTRA
# of Institutions
663Shares Held
126MCall Options Held
982KPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.71 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.45 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.02 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$934 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$628 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $13.4B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...